Immunome Inc.
IMNMCIK 0001472012 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
110,000 bought / 411,050 sold
net −301,050 sh · −$8.18M
- buys
- 2
- sells
- 10
- insiders active
- 2
Filing tape
Filed Tue, Jul 7, 2026
- −0 sh · $764.2K
Lechleider Robert — Chief Medical Officer
- Exercised55,000Common Stock@ $8.73→ 70,805 held
- Sold22,714Common Stock@ $21.95→ 48,091 held
- Sold16,214Common Stock@ $22.76→ 31,877 held
- Sold16,072Common Stock@ $23.44→ 15,805 held
- Exercised55,000Employee Stock Option (right to buy)→ 290,000 held
- −100,000 sh · $2.41M
Barchas Isaac — Director
- Sold83,094Common Stock@ $24.11→ 125,410 held
- Sold16,906Common Stock@ $24.20→ 108,504 held
Filed Thu, Jul 2, 2026
- −201,050 sh · $4.39M
Barchas Isaac — Director
- Sold101,050Common Stock@ $21.12→ 308,504 held
- Sold75,665Common Stock@ $22.35→ 232,839 held
- Sold24,335Common Stock@ $23.33→ 208,504 held
Filed Mon, Jun 29, 2026
- −0 sh · $611.5K
Lechleider Robert — Chief Medical Officer
- Exercised55,000Common Stock@ $8.73→ 70,805 held
- Sold40,580Common Stock@ $19.56→ 30,225 held
- Sold14,420Common Stock@ $20.66→ 15,805 held
- Exercised55,000Employee Stock Option (right to buy)→ 345,000 held
Insiders on this tape
- Lechleider RobertChief Medical Officer
- Barchas IsaacDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.